Soham Yande, PhD

Senior Health Outcomes Scientist, Health Economics

Practice Area

Office Location

Headquarters - Research Triangle Park, North Carolina, USA

PhD, Pharmaceutical Health Outcomes and Policy
University of Houston, Houston, TX

BPharm, Pharmacy
University of Mumbai, Mumbai, India

Soham Yande, PhD, is a Senior Health Outcomes Scientist in the Health Economics group with RTI-HS. He has over 5 years of experience in designing and carrying out outcomes research studies. Dr. Yande has conducted research in various therapeutic areas, including oncology, diabetes, and psychiatry and has expertise in studies involving claims and EMR data analysis. He also has expertise using analytical software including SAS, R, and SPSS.

Send Soham Yande a message

Full Name

Business Title

Organization

Technical Area

Attachments

You may attach up to three PDF, Word or Excel documents.

Each document must be under 2 MB.

Maximum 3 files.
2 MB limit.
Allowed types: pdf, doc, docx, xls, xlsx, txt.

Your message

Yes, I would like to receive updates on RTI-HS news, information, and events.

By submitting this form, you accept the RTI-HS privacy policy.

Selected Recent Publications

Yande S, Johnson ML, Aparasu RR, Toale K, Wanat M. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins in cancer associated thrombosis. Poster presented at the ISPOR 2024; May 7, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S179. doi: 10.1016/j.jval.2024.03.969

Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24

Johnson ML, Yande S, Aparasu RR, Wanat M, Toale K. Prevalence and factors associated with the use of direct oral anticoagulants and low molecular weight heparins (LMWH) in cancer patients. Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S377-8. doi: 10.1016/j.jval.2023.03.2121

Saxena K, Sawhney B, Yande S, Kathe N, Chatterjee S. The burden of cervical conization in privately insured young and mid-adult women in the United States. Vaccines (Basel). 2023 Apr 5;11(4):804. doi: 10.3390/vaccines11040804

More Publications